Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF

Published:2015-09-04 Issue:4 Volume:46 Page:1217-1221
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Milger Katrin,Kneidinger Nikolaus,Neurohr Claus,Reichenberger Frank,Behr Jürgen

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference14 articles.

1. Antifibrotic activities of pirfenidone in animal models

2. BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

3. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

4. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

5. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerability and efficacy of switching anti-fibrotic treatment from nintedanib to pirfenidone for idiopathic pulmonary fibrosis;PLOS ONE;2024-06-13

2. The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry;Archivos de Bronconeumología;2024-02

3. Pharmakotherapie der idiopathischen Lungenfibrose (ein Update) und anderer progredienter pulmonaler Fibrosen;Pneumologie;2023-02

4. DISEASE PROGRESSION IN IDIOPATHIC PULMONARY FIBROSIS UNDER ANTI-FIBROTIC TREATMENT;SARCOIDOSIS VASC DIF;2023

5. Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols;Disease-a-Month;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3